Rx-360 Summary of FDA's Supply Chain Security Pilot Programme
On 20 August, FDA announced the initiation of a pilot import program. The Secure Supply Chain Pilot Program will launch in 2014 and, pending the outcome, it may become permanent.
FDA is seeking 100 applicants for the pilot program with no more than five drug products per applicant. This programme is associated with Section 713 of FDASIA that “…authorises FDA to require the submission of drug compliance information as a condition of granting admission to imported drugs…” including generation of regulations that may allow FDA to treat companies differently based on their compliance history and type of import. This may permit expedited import of materials by and from highly compliant companies.
The FDA announcement specifies 12 requirements that must be met by applicants to the pilot program, including
• Completion of the necessary application
• The ultimate consignee must be in compliance with FDA registration and listing requirements and GMPs, including compliance during the past 3 years
• For imported finished dosage form, the consignee must be identified in the approved NDA/ANDA
• For imported API, the source must be identified in the NDA/ANDA and be used to manufacture an FDA approved product.
• The foreign manufacturer of finished dosage form or API must be in compliance with the FD&C Act
• The applicant must have an adequate system in place to effect a recall or field correction
• Applicants must have an adequate system to comply with record keeping requirements specified in the FD&C Act and its implementing regulations.
Related News
-
News Pharmaceutical industry supports COP28 health stance in joint statement
As COP28 takes place over this week in Dubai, UAE, several bodies in the pharmaceutical and health industries have come together to announce support of key movements in sustainability in the sector, and to recognise sustainability as a health issue.&nb... -
News Biden backs Cold-War measures to shore-up medical supply chains
In a recent strategy to combat rising inflation and the cost of living crisis, President Joe Biden has invoked a Cold War-era act to increase investment in a selection of medicines and supplies. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Novartis agrees for copies to be made of cancer drug to reach poorer countries
Novartis signs agreement with MPP to have generics of it's leukemia drug made so that it can be more easily distributed to the world's poorer countries. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute. -
News New WHO health emergency guidelines expect full transparency from Big Pharma
The WHO are proposing a new set of pandemic guidelines to set out how future global health crises should be handled.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance